Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma.

@article{Hoskin2005LongtermRO,
  title={Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma.},
  author={Peter J. Hoskin and Paul J. Smith and Timothy S. Maughan and Di Gilson and Cheryl Vernon and Isabel Syndikus and David Christopher Linch},
  journal={Clinical oncology (Royal College of Radiologists (Great Britain))},
  year={2005},
  volume={17 1},
  pages={47-53}
}
Involved field (IF) radiation was compared with extended field (EF) radiation in Hodgkin lymphoma (HL) to ascertain whether reduced radiation fields would reduce the late sequelae of radiation without compromising disease control and survival. A total of 603 patients with stage I or II HL were entered into this trial; laparotomy was carried out in 380 (63%) patients. Stage I or IIA disease patients were randomised to receive IF or EF comprising a mantle or inverted Y fields alone. Stage I and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Management of early-stage Hodgkin lymphoma: is there still a role for radiation?

Hematology. American Society of Hematology. Education Program • 2013

Criteria for deciding cost-effectiveness for expensive new anti-cancer agents.

Journal of cancer research and therapeutics • 2008
View 2 Excerpts

Similar Papers

Loading similar papers…